Zacks Investment Research cut shares of Owens & Minor (NYSE:OMI) from a hold rating to a sell rating in a research report sent to investors on Tuesday.

According to Zacks, “Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor’s customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. “

A number of other research analysts also recently commented on OMI. Barclays reiterated a sell rating and set a $6.00 target price on shares of Owens & Minor in a research report on Sunday, January 6th. Bank of America lowered their target price on Owens & Minor from $11.00 to $7.00 and set a neutral rating for the company in a research report on Thursday, January 3rd. Jefferies Financial Group reiterated a hold rating and set a $8.50 target price on shares of Owens & Minor in a research report on Friday, November 2nd. Finally, Leerink Swann set a $9.00 target price on Owens & Minor and gave the company a hold rating in a research report on Wednesday, October 31st. Four analysts have rated the stock with a sell rating and three have given a hold rating to the company. The company has a consensus rating of Sell and a consensus price target of $10.10.

Owens & Minor stock opened at $7.36 on Tuesday. The company has a market capitalization of $438.37 million, a P/E ratio of 4.57, a PEG ratio of 1.53 and a beta of 1.63. Owens & Minor has a 12-month low of $5.83 and a 12-month high of $22.91. The company has a quick ratio of 0.88, a current ratio of 1.71 and a debt-to-equity ratio of 2.07.

Owens & Minor (NYSE:OMI) last released its earnings results on Wednesday, October 31st. The company reported $0.32 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.32. Owens & Minor had a negative net margin of 1.57% and a positive return on equity of 9.50%. The company had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.54 billion. During the same period in the prior year, the firm posted $0.40 EPS. The firm’s quarterly revenue was up 5.6% compared to the same quarter last year. Analysts forecast that Owens & Minor will post 1.22 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 2nd. Investors of record on Monday, December 17th were given a $0.075 dividend. The ex-dividend date was Friday, December 14th. This represents a $0.30 dividend on an annualized basis and a yield of 4.08%. Owens & Minor’s dividend payout ratio is presently 18.63%.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. North Star Investment Management Corp. increased its stake in Owens & Minor by 4.6% in the fourth quarter. North Star Investment Management Corp. now owns 127,355 shares of the company’s stock worth $806,000 after purchasing an additional 5,648 shares during the period. Vanguard Group Inc increased its stake in Owens & Minor by 0.5% in the third quarter. Vanguard Group Inc now owns 6,381,521 shares of the company’s stock worth $105,422,000 after purchasing an additional 33,197 shares during the period. Vanguard Group Inc. increased its stake in Owens & Minor by 0.5% in the third quarter. Vanguard Group Inc. now owns 6,381,521 shares of the company’s stock worth $105,422,000 after purchasing an additional 33,197 shares during the period. Morgan Stanley increased its stake in Owens & Minor by 23.7% in the third quarter. Morgan Stanley now owns 1,372,424 shares of the company’s stock worth $22,673,000 after purchasing an additional 262,792 shares during the period. Finally, Legal & General Group Plc increased its stake in Owens & Minor by 8.4% in the third quarter. Legal & General Group Plc now owns 205,054 shares of the company’s stock worth $3,392,000 after purchasing an additional 15,863 shares during the period. Institutional investors own 88.83% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare services company in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. It operates through three segments: Domestic, International, and Proprietary Products. The company offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices.

Recommended Story: Marijuana Stocks Future Looks Bright

Get a free copy of the Zacks research report on Owens & Minor (OMI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.